|
|
|
|
Weekly CEO Buys Highlight: Bruker BioSciences Corp, Dynex Capital Inc, American Dairy Inc, Pioneer Drilling Co
Last weeks top five stocks that were bought by their CEOs were Bruker BioSciences Corp, Dynex Capital Inc, American Dairy Inc, Pioneer Drilling Company, MettlerToledo International Inc.According to , these are the largest CEO buys during the past week.
|
|
|
Agennix AG Raises EUR 9.8 Million (Approximately $13 Million) in Private Placement With Existing Shareholders
Agennix AG (FRANKFURT: AGX) today announced that the Company has raised approximately EUR 9.8 million (approximately $13 million) in a private placement with existing shareholders.Agennix sold 1,870,523 shares at a price of EUR 5.22 per share....
|
|
|
NexMed Bolsters Its Cash Reserve with $1.4 Million Infusion from Successful Mortgage Refinancing on Its New Je
- NexMed, Inc.(Nasdaq:NEXM), a specialty CRO with a pipeline of products based on the NexACT technology, announced today that it raised $1.4 million in gross proceeds from refinancing the mortgage on its manufacturing facility in New Jersey. The mortgage...
|
|
|
Merge Commences Tenders for AMICAS' Outstanding Shares
Merge Healthcare, a health IT solutions provider, announced that it has commenced a tender offer for all of the outstanding shares of common stock in AMICAS, Inc., a leader in image and information management solutions.The tender offer is being...
|
|
|
PDL BioPharma Announces Conversion Rate Adjustments to Convertible Notes
- Company Clarifies Facet Stock Distribution Value - INCLINE VILLAGE, Nev., March 15 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc.(PDL) (NASDAQ:PDLI) today announced adjustments to the conversion rates for its 2.00% Convertible Senior Notes due February 15,...
|
|
|
Merge Healthcare commences tender offer for all outstanding common stock shares of AMICAS
Merge Healthcare (NASDAQ: MRGE) ('Merge'), a health IT solutions provider, announced today that it has commenced a tender offer for all of the outstanding shares of common stock in AMICAS, Inc.(NASDAQ: AMCS) ('AMICAS'), a leader in image and...
|
|
|
Marshall Edwards, Inc. Receives Nasdaq Staff Determination
NEW CANAAN, CT (MARKET WIRE) 03/19/10 Marshall Edwards, Inc.(NASDAQ: MSHL), a specialist oncology company focusing on the clinical development of novel anti-cancer therapeutics, announced today that on March 16, 2010, it received written notification (the ...
|
|
|
NYSE Transaction Leaders F, BAC, C, GE and PFE
Ft Lauderdale, Florida 3/19/2010 08:50 PM GMT (TransWorldNews) NYSE transaction leaders in morning trading on Friday, March 19, 2010 are Ford Motor Company, Bank of America, Citigroup, General Electric and Pfizer.The NYSE transaction leaders are as follows....
|
|
|
Golden Minerals Company Prices US$41.7 Million Offering and Announces Approval of NYSE AMEX Listing
Golden Minerals Company (TSX: AUM) ('Golden Minerals' or 'the Company') today announced the pricing of its public offering of 4,000,000 shares of common stock at a price of US$8.50 per share.A total of 3,652,234 shares are being...
|
|
|
AVEO Pharmaceuticals raises $81 million through initial public of...
Company: AVEO Pharmaceuticals Inc (AVEO) AVEO Pharmaceuticals, Inc., a US-based biopharmaceutical company developing cancer therapeutics, has completed its initial public offering (IPO) of 9 million shares of its common stock at a price of $9 per ...
|
|
|
AVEO Pharmaceuticals raises $81 million through initial public offering
AVEO Pharmaceuticals, Inc., a US-based biopharmaceutical company developing cancer therapeutics, has completed its initial public offering (IPO) of 9 million shares of its common stock at a price of $9 per share raising gross proceeds of $81...
|
|
|
FDA Denies Approval For A. P. Pharma's Nausea Treatment
The Food and Drug Administration issued a complete response letter to A.Pharma Inc. (Nasdaq: APPA) denying approval for the company's chemotherapy induced nausea treatment APF530 sending the stock price plummeting 91 cents to $1.15. The Food and...
|
|
|
Dundee Corporation Acquires Interest in Energizer Resources Inc
In accordance with regulatory requirements, Dundee Corporation (TSX: DC.A) ('Dundee Corp.') announced today that it has acquired an aggregate of 10,000,000 units of Energizer Resources Inc.('Energizer') at a price of US$0.30 per unit (each a 'Unit')...
|
|
|
A.P. Pharma, Netlist: Early Volume Plays
YORK (TheStreet) -- Several stocks trading near $5 were moving on above-average volume during Friday's session.Pharma (APPA) dropped by $1.08, or 52.7%, to 97 cents after the Food and Drug Administration did not approve its experimental drug APF530 for the...
|
|
|
Bucking Horse Energy Inc. Announces Acquisition of Securities Through Settlement of Outstanding Debt
2:10 PM EST Bucking Horse Energy Inc.(the 'Company' and 'Bucking Horse') (TSX: BUC) announces that it has acquired through its wholly-owned subsidiary Gemini Energy Corp. ('Gemini') 600,000 common shares of XXL Energy Corp. ('XXL'). The...
|
|
|
Pinetree Capital Ltd. Acquires Securities of Kirrin Resources Inc
common shares ('Common Shares') and 1,500,000 common share purchase warrants (the 'Warrants') of Kirrin Resources Inc.('Kirrin'). Each Warrant entitles the holder thereof to acquire one additional common share at a price of $0...
|
|
|
MBMI Closes Private Placement
3:30 PM EST MBMI RESOURCES INC.('MBMI' or the 'Company') (TSX VENTURE: MBR) reports that further to its January 29, 2010 news release, it has closed the first two tranches of its non-brokered Private Placement financing. The Company has received gross...
|
|
|
Stockguru.com: PROLOR Biotech Inc. is in the StockGuru Spotlight for March 19, 2010
On Thursday, the company put out news announcing that the company has raised $24.4 million in a private placement of 10,382,975 shares of its common stock, par value $0.00001 per share, to accredited investors at a price of $2.35 per share,...
|
|
|
Derma Sciences, Inc. (DSCI) Announces Full Exercise of Over-Allotment Option and Closing of Public Equity Offe
/PRNewswire via COMTEX/ -- /quotes/comstock/15*!dsci/quotes/nls/dsci (DSCI 5.69, -0.09, -1.56%) , a specialty medical device/pharmaceutical company focused on advanced wound care, today announced that the underwriter of its recent public offering has exercised...
|
|
|
Commercial Vehicle Group expects $22M in offering
Heavy truck equipment supplier Commercial Vehicle Group Inc.said Friday it expects its public offering of 3.8 million shares at $6.25 a share will result in proceeds of at least $22 million, after expenses. The company plans to use the proceeds...
|
|
|
Marshall Edwards, Inc. (NVGN) Receives Nasdaq Staff Determination
- Highlighted Links (NASDAQ: MSHL), a specialist oncology company focusing on the clinical development of novel anti-cancer therapeutics, announced today that on March 16, 2010, it received written notification (the 'Staff Determination') from The Nasdaq Stock...
|
|
|
Abraham, Fruchter & Twersky, LLP Announces Filing of a Class Action Lawsuit Against AMAG Pharmaceuticals, Inc.
The complaint charges the Company and certain of its officers with violations of the Securities Act.AMAG is a biopharmaceutical company engaged in the development and commercialization of therapeutic iron compounds to treat anemia worldwide. According to...
|
|
|
Theravance Announces Pricing of Public Offering of Common Stock
Theravance, Inc.(NASDAQ: THRX), a biopharmaceutical company with a pipeline of internally discovered product candidates, today announced that it has priced its public offering of 7,500,000 shares of its common stock at a price to the public...
|
|
|
Marshall Edwards, Inc. Receives Nasdaq Staff Determination
Marshall Edwards, Inc.(NASDAQ: MSHL), a specialist oncology company focusing on the clinical development of novel anti-cancer therapeutics, announced today that on March 16, 2010, it received written notification (the 'Staff Determination') from The Nasdaq...
|
|
|
Abraham, Fruchter & Twersky, LLP Announces Filing of a Class Action Lawsuit Against AMAG Pharmaceuticals, Inc
The complaint charges the Company and certain of its officers with violations of the Securities Act.AMAG is a biopharmaceutical company engaged in the development and commercialization of therapeutic iron compounds to treat anemia worldwide. According to...
|
